News

  • Loan round-up: Hempel, Iberdrola, Preem, LGIM ... and more

    28 April 2022
  • NGFS backs ISSB in push for consistency on transition finance

    27 April 2022

    A group of central bankers have added their weight to calls for more rapid harmonisation of approaches to assessing 'green and transition finance'.

  • Banks 'resisting SBTi fossil fuel phase-out goals'

    27 April 2022

    Some banks in the US and Asia continue to resist the Science-Based Targets initiative (SBTi)'s proposed timeline for phasing out financing for fossil fuels, a member of the think tank has said.

  • Bond round-up: OMERS, Bank of China, Jabil, Singtel ... and more

    27 April 2022
  • New York State Retirement Fund supports proposal to stop underwriting fossil fuels

    27 April 2022

    The New York State comptroller has pledged to support of shareholder proposals that ask three insurance companies to stop underwriting new fossil fuel supplies.

  • ASN invests €2m in Clarmondial sustainable food fund

    27 April 2022

    Dutch firm ASN Impact Investors has invested €2 million ($2.1 million) in Clarmondial's fund focused on sustainable agriculture.

  • "We are creating a bad climate premium," warns FRR director

    27 April 2022

    Bad assets are going to bad asset owners, says executive at €1.8trn fund

  • Climate policy since COP26 'confirming 1.8֯ C trajectory'

    27 April 2022

    Climate policy developments since November's UN climate conference "reflect slight positives in global climate ambition," according to an analysis.

  • Moody's unveils ESG portfolio screening kit

    27 April 2022

    Moody's has launched a data platform that provides access to Moody's physical and transition climate risk data sets across a recently expanded universe of 10,000 companies globally.

  • Biodiversity regulation 'where climate regulation was 8 years ago'

    27 April 2022

    Regulation of investor impacts and dependencies on nature is today where it was about eight years ago for climate change, according to a member of a high-profile study group.